NYKODE THERAPEUTICS ASA earnings per share and revenue

NYKD earnings per share for the last quarter are -0.48 NOK whereas the estimation was -0.50 NOK which accounts for 3.30% surprise. Företagets omsättning för samma period uppgår till 10.79 M NOK trots den uppskattade siffran 64.37 M NOK. Estimated earnings per share for the next quarter are -0.53 NOK, and revenue is expected to reach 65.39 M NOK. Also watch annual changes over time to get a bigger picture of NYKD earnings per share and revenue dynamics.